269 results
Event
Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
February 15, 2024
Webinar
Event
Inducement to Infringe in Hatch-Waxman Litigation: Strategies for Patent Drafting, Prosecution, and Litigation Inducement to Infringe in Hatch-Waxman Litigation: Strategies for Patent Drafting, Prosecution, and Litigation
December 14, 2023
Webinar
Event
Patent Infringement, Safe Harbor, and Drug Development: Navigating the Uncertain Boundaries, Recent Court Treatment Patent Infringement, Safe Harbor, and Drug Development: Navigating the Uncertain Boundaries, Recent Court Treatment
November 30 2023
Webinar
Event
Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval Biosimilars and Interchangeable Biologics: New FDA Draft Guidance Clarifying Application Process for Approval
November 28, 2023
Webinar
Event
California Lawyers Association 47th IP Institute California Lawyers Association 47th IP Institute
November 2-4, 2023
San Diego
Event
2023 Life Sciences: Future-Ready Resilience 2023 Life Sciences: Future-Ready Resilience
May 9-11, 2023
South San Francisco
3 results
Media Mention
Nestle Gets Another Chance in Bottling Patent Fight Nestle Gets Another Chance in Bottling Patent Fight
May 10, 2017
Bloomberg BNAMedia Mention
Boston Law Firms Among Most Active for New-drug Lawsuits Boston Law Firms Among Most Active for New-drug Lawsuits
May 8, 2017
Boston Business JournalMedia Mention
Cumberland Beats Mylan Challenge to Acetadote Patent Right Cumberland Beats Mylan Challenge to Acetadote Patent Right
January 27, 2017
Bloomberg BNADue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.